InvestorsHub Logo
Followers 8
Posts 3893
Boards Moderated 1
Alias Born 06/28/2005

Re: None

Tuesday, 08/21/2012 6:36:05 PM

Tuesday, August 21, 2012 6:36:05 PM

Post# of 45771
Crow, just look at the amount owed to ASD on the creditors list and that will show that CDEx was (is) paying a hefty royalty fee for the privilege of using ASD's patented technology without admitting fault.

I was surprised at how high it is considering how few Valimeds have been "placed".

The chance of CDEx producing an iG4* that's useful: 10 million:1

The chance of CDEx producing an iG4* that's useful without once again being sued for infringement: 100 million:1


* as advertisted
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.